Adaptive Biotechnologies
ADPT
Insidertransaktionen und Aktienkurs 2024-2026
Alle Insidertrades bei Adaptive Biotechnologies
| Datum |
Typ |
Insider |
Position |
Ø-Preis |
Volumen |
|
30.7.2026
|
Verkauf |
Bobulsky, Susan |
Chief Commercial Officer, MRD |
24,0 $ |
31.176 $ |
|
21.7.2026
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
21,9 $ |
10.780.409 $ |
|
16.7.2026
|
Verkauf |
Bobulsky, Susan |
Chief Commercial Officer, MRD |
23,0 $ |
115.000 $ |
|
15.7.2026
|
Verkauf |
Lo, Francis |
Chief People Officer |
22,6 $ |
2.389.164 $ |
|
2.7.2026
|
Verkauf |
Lo, Francis |
Chief People Officer |
22,6 $ |
1.012.890 $ |
|
2.7.2026
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
22,1 $ |
8.501.149 $ |
|
1.7.2026
|
Verkauf |
Lo, Francis |
Chief People Officer |
22,3 $ |
1.144.793 $ |
|
1.7.2026
|
Verkauf |
Bobulsky, Susan |
Chief Commercial Officer, MRD |
22,0 $ |
10.714 $ |
|
29.6.2026
|
Verkauf |
Benzeno, Sharon |
Chief Commercial Ofc Imm Med |
21,1 $ |
3.271.796 $ |
|
26.6.2026
|
Verkauf |
Benzeno, Sharon |
Chief Commercial Ofc Imm Med |
21,0 $ |
231.714 $ |
|
25.6.2026
|
Verkauf |
Griffin, Michelle Renee |
Aufsichtsrat |
20,2 $ |
1.051.055 $ |
|
25.6.2026
|
Verkauf |
Bobulsky, Susan |
Chief Commercial Officer, MRD |
20,5 $ |
102.500 $ |
|
16.6.2026
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
18,0 $ |
110.942 $ |
|
15.6.2026
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
17,4 $ |
1.737.000 $ |
|
11.6.2026
|
Verkauf |
Bobulsky, Susan |
Chief Commercial Officer, MRD |
19,0 $ |
95.000 $ |
|
4.6.2026
|
Verkauf |
Lo, Francis |
Chief People Officer |
17,5 $ |
695.070 $ |
|
4.6.2026
|
Verkauf |
Bobulsky, Susan |
Chief Commercial Officer, MRD |
18,0 $ |
198.000 $ |
|
18.5.2026
|
Verkauf |
Piskel, Kyle |
Chief Financial Officer |
13,0 $ |
40.620 $ |
|
27.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,2 $ |
270.897 $ |
|
24.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,0 $ |
267.221 $ |
|
23.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,7 $ |
261.884 $ |
|
22.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,1 $ |
269.318 $ |
|
21.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,7 $ |
453.595 $ |
|
20.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,6 $ |
277.323 $ |
|
17.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,6 $ |
277.704 $ |
|
16.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,2 $ |
270.271 $ |
|
15.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,6 $ |
278.467 $ |
|
14.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,6 $ |
277.514 $ |
|
13.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,5 $ |
250.599 $ |
|
10.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,1 $ |
243.307 $ |
|
9.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,1 $ |
264.202 $ |
|
8.4.2026
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
15,2 $ |
566.025 $ |
|
8.4.2026
|
Verkauf |
Lo, Francis |
Chief People Officer |
15,1 $ |
340.039 $ |
|
8.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
15,2 $ |
458.920 $ |
|
8.4.2026
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
14,8 $ |
148.500 $ |
|
7.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,6 $ |
258.454 $ |
|
6.4.2026
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
14,4 $ |
1.200.814 $ |
|
6.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,3 $ |
273.130 $ |
|
2.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,6 $ |
278.276 $ |
|
1.4.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,4 $ |
275.417 $ |
|
31.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,4 $ |
256.357 $ |
|
30.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
12,6 $ |
240.728 $ |
|
27.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,0 $ |
254.219 $ |
|
26.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,1 $ |
269.127 $ |
|
25.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,3 $ |
271.986 $ |
|
24.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,7 $ |
261.122 $ |
|
23.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,8 $ |
263.600 $ |
|
20.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,4 $ |
254.832 $ |
|
19.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,2 $ |
251.211 $ |
|
18.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,2 $ |
251.211 $ |
|
17.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,4 $ |
255.404 $ |
|
16.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,4 $ |
255.595 $ |
|
13.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,0 $ |
247.018 $ |
|
12.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,0 $ |
245.048 $ |
|
11.3.2026
|
Verkauf |
Griffin, Michelle Renee |
Aufsichtsrat |
13,9 $ |
214.131 $ |
|
11.3.2026
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
13,2 $ |
6.192.099 $ |
|
11.3.2026
|
Verkauf |
Lo, Francis |
Chief People Officer |
14,1 $ |
430.749 $ |
|
11.3.2026
|
Verkauf |
Piskel, Kyle |
Chief Financial Officer |
13,2 $ |
245.910 $ |
|
11.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
13,6 $ |
1.881.993 $ |
|
11.3.2026
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
13,2 $ |
6.193.403 $ |
|
11.3.2026
|
Verkauf |
Benzeno, Sharon |
Chief Commercial Ofc Imm Med |
13,2 $ |
831.067 $ |
|
11.3.2026
|
Verkauf |
Bobulsky, Susan |
Chief Commercial Officer, MRD |
13,2 $ |
544.421 $ |
|
10.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,7 $ |
285.673 $ |
|
9.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
14,8 $ |
457.617 $ |
|
6.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
15,1 $ |
468.447 $ |
|
5.3.2026
|
Verkauf |
Lo, Francis |
Chief People Officer |
15,1 $ |
574.537 $ |
|
5.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
16,0 $ |
495.056 $ |
|
4.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
16,6 $ |
513.621 $ |
|
3.3.2026
|
Verkauf |
Griffin, Michelle Renee |
Aufsichtsrat |
15,3 $ |
735.073 $ |
|
3.3.2026
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
15,8 $ |
823.826 $ |
|
3.3.2026
|
Verkauf |
Rubinstein, Julie |
President and COO |
15,9 $ |
484.751 $ |
|
3.3.2026
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
16,5 $ |
235.129 $ |
|
2.3.2026
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
15,8 $ |
4.572.360 $ |
|
2.3.2026
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
15,7 $ |
157.200 $ |
|
27.2.2026
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
16,0 $ |
2.924.427 $ |
|
4.2.2026
|
Verkauf |
Piskel, Kyle |
Chief Financial Officer |
18,5 $ |
39.597 $ |
|
3.2.2026
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
19,0 $ |
154.280 $ |
|
2.2.2026
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
18,4 $ |
2.304.963 $ |
|
2.2.2026
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
18,6 $ |
644.825 $ |
|
12.1.2026
|
Verkauf |
Lo, Francis |
Chief People Officer |
17,7 $ |
1.411.131 $ |
|
12.1.2026
|
Verkauf |
Piskel, Kyle |
Chief Financial Officer |
18,0 $ |
77.220 $ |
|
6.1.2026
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
16,4 $ |
164.400 $ |
|
5.1.2026
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
15,6 $ |
1.948.719 $ |
|
2.1.2026
|
Verkauf |
Lo, Francis |
Chief People Officer |
16,1 $ |
50.250 $ |
|
22.12.2025
|
Verkauf |
Lo, Francis |
Chief People Officer |
17,5 $ |
153.790 $ |
|
15.12.2025
|
Verkauf |
Lo, Francis |
Chief People Officer |
15,6 $ |
1.773.267 $ |
|
10.12.2025
|
Verkauf |
Hershberg, Robert |
Aufsichtsrat |
16,0 $ |
367.488 $ |
|
4.12.2025
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
16,6 $ |
166.100 $ |
|
4.12.2025
|
Verkauf |
Benzeno, Sharon |
Chief Commercial Ofc Imm Med |
16,8 $ |
212.377 $ |
|
3.12.2025
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
18,6 $ |
506.415 $ |
|
1.12.2025
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
18,9 $ |
2.367.462 $ |
|
28.11.2025
|
Verkauf |
Piskel, Kyle |
Chief Financial Officer |
19,5 $ |
3.174.990 $ |
|
26.11.2025
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
19,7 $ |
703.284 $ |
|
21.11.2025
|
Verkauf |
Benzeno, Sharon |
Chief Commercial Ofc Imm Med |
16,9 $ |
5.216.346 $ |
|
20.11.2025
|
Verkauf |
Benzeno, Sharon |
Chief Commercial Ofc Imm Med |
16,5 $ |
4.927.680 $ |
|
17.11.2025
|
Verkauf |
Piskel, Kyle |
Chief Financial Officer |
14,0 $ |
3.344 $ |
|
12.11.2025
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
15,0 $ |
28.005 $ |
|
11.11.2025
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
14,6 $ |
18.023 $ |
|
10.11.2025
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
14,7 $ |
1.269.152 $ |
|
10.11.2025
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
14,8 $ |
148.200 $ |
|
16.5.2025
|
Verkauf |
Piskel, Kyle |
Chief Financial Officer |
8,9 $ |
34.298 $ |
|
1.5.2025
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
7,4 $ |
502.828 $ |
|
24.3.2025
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
9,0 $ |
15.282 $ |
|
13.3.2025
|
Verkauf |
Griffin, Michelle Renee |
Aufsichtsrat |
7,2 $ |
260.932 $ |
|
12.3.2025
|
Verkauf |
Hershberg, Robert |
Aufsichtsrat |
7,6 $ |
402.270 $ |
|
10.3.2025
|
Verkauf |
Neupert, Peter M. |
Aufsichtsrat |
7,0 $ |
70.500 $ |
|
6.3.2025
|
Verkauf |
Griffin, Michelle Renee |
Aufsichtsrat |
7,9 $ |
124.372 $ |
|
6.3.2025
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
7,6 $ |
780.946 $ |
|
5.3.2025
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
7,0 $ |
819.472 $ |
|
5.3.2025
|
Verkauf |
Robins, Harlan S. |
Chief Scientific Officer |
7,0 $ |
675.219 $ |
|
5.3.2025
|
Verkauf |
Rubinstein, Julie |
President and COO |
7,0 $ |
415.539 $ |
|
5.3.2025
|
Verkauf |
Piskel, Kyle |
Chief Financial Officer |
7,0 $ |
72.072 $ |
|
5.3.2025
|
Verkauf |
Benzeno, Sharon |
Chief Commercial Ofc Imm Med |
7,0 $ |
311.792 $ |
|
5.3.2025
|
Verkauf |
Bobulsky, Susan |
Chief Commercial Officer, MRD |
7,0 $ |
181.641 $ |
|
5.3.2025
|
Verkauf |
Lo, Francis |
Chief People Officer |
7,0 $ |
145.845 $ |
|
20.2.2025
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
8,4 $ |
836.463 $ |
|
19.2.2025
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
8,5 $ |
1.574.237 $ |
|
18.2.2025
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
8,5 $ |
1.794.860 $ |
|
14.2.2025
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
8,5 $ |
1.344.472 $ |
|
13.2.2025
|
Verkauf |
Robins, Chad M. |
CEO and Chairman |
8,4 $ |
846.422 $ |
|
18.11.2024
|
Verkauf |
Piskel, Kyle |
Chief Financial Officer |
5,0 $ |
1.235 $ |
|
22.8.2024
|
Verkauf |
Taylor, Stacy L. |
SVP and General Counsel |
4,5 $ |
121.079 $ |
Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Verfolge die Insiderkäufe in Echtzeit per Push in unserem Telegram-Channel.
Jetzt beitreten